Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generalized anxiety disorder.

Ray Pary1, Paul R Matuschka, Susan Lewis

  • 1Mental Health and Behavioral Science and Pharmacy Service, Department of Veterans Affairs, Louisville, KY, USA. raymond.pary@med.va.gov

Southern Medical Journal
|August 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do We Really Care About Our Children's School Safety? The Proof Is in the Pudding.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same author

Can You Properly Manage Delusional Parasitosis?

Innovations in clinical neuroscience·2025
Same author

Resurgence of polio and the path to eradication.

Tropical medicine & international health : TM & IH·2025
Same author

Babesiosis - An Unseen Epidemic.

WMJ : official publication of the State Medical Society of Wisconsin·2025
Same author

When Suicidality Is Suspected.

Southern medical journal·2025
Same author

Firearm Shootings: A Serious Public Health Issue.

Southern medical journal·2025
Same journal

SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

Southern medical journal·2026
Same journal

Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

Southern medical journal·2026
Same journal

Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

Southern medical journal·2026
Same journal

Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

Southern medical journal·2026
Same journal

Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

Southern medical journal·2026
Same journal

Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

Southern medical journal·2026
See all related articles

Generalized anxiety disorder (GAD) requires treatment when it disrupts daily functioning. Current pharmacotherapy trends favor antidepressants over long-term benzodiazepines due to dependence risks.

Area of Science:

  • Psychiatry and Behavioral Sciences
  • Pharmacology
  • Clinical Psychology

Background:

  • Anxiety is a common human experience, but moderate to severe levels can cause significant distress and functional impairment.
  • Generalized Anxiety Disorder (GAD) is a chronic condition marked by excessive worry and specific physical and cognitive symptoms for at least six months.
  • Pharmacotherapy is the primary treatment for anxiety disorders.

Purpose of the Study:

  • To review the current landscape of anxiety pharmacotherapy.
  • To highlight the shift in treatment paradigms for anxiety disorders.
  • To discuss the limitations of traditional benzodiazepine therapy.

Main Methods:

  • Literature review of pharmacological treatments for anxiety disorders.

Related Experiment Videos

  • Analysis of treatment trends from benzodiazepine monotherapy to combination therapies.
  • Evaluation of the side effect profiles and long-term risks associated with different medication classes.

    • Main Results:

    • Medication for anxiety has evolved from solely benzodiazepines to combined benzodiazepine and antidepressant approaches.
    • Long-term benzodiazepine use is associated with significant drawbacks including physical dependence, tolerance, and withdrawal.
    • Serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are increasingly supported for anxiety treatment.

    Conclusions:

    • The treatment of generalized anxiety disorder is shifting towards medications with better long-term safety profiles.
    • SSRIs and SNRIs represent a more favorable option for managing anxiety disorders compared to exclusive long-term benzodiazepine use.
    • Understanding the risks and benefits of different pharmacotherapies is crucial for effective anxiety management.